Biotech

All Articles

Cullinan, after $25M bargain, restore bispecific to Harbour

.Cullinan Therapy was made an impression on sufficient along with Harbour BioMed's bispecific immune...

A closer look at Fierce Biotech's Brutal 15

.In this particular full week's incident of "The Leading Pipe," our team're diving into Intense Biot...

Lilly experiences phase 2 breakdown of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's party commemorating the approval of ...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of considerable management hirings, shootings a...

Lykos will inquire FDA to reexamine its decision following rejection of MDMA therapy for trauma

.Complying with a poor showing for Lykos Rehabs' MDMA prospect for trauma at a recent FDA advisory c...

AN 2 one-halfs head count, quits period 3 trial after data disappoint

.AN2 Rehabs is reviewing its own organization in action to dull midphase records, pledging to give u...

Merck pays $700M for bispecific, spying autoimmune opening as well as possibility to test Amgen in cancer cells

.Merck &amp Co. is actually spending $700 thousand upfront to challenge Amgen in a blood cancer mark...

Gilead spends J&ampJ $320M to leave licensing bargain for seladelpar

.Along With Gilead Sciences on the verge of an FDA decision for its own liver health condition medic...

' All palms on deck' at Lilly as peers target weight problems market

.CEO David Ricks can easily find the providers setting up outdoors tents at basecamp responsible for...

Entero giving up team, vacating office as well as stopping briefly R&ampD

.Bed Liquidators has transformed Entero Therapeutics white as a sheet. The collector purchased Enter...